| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |